Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.

The Journal of antimicrobial chemotherapy - 1 Oct 2024

Luzarraga Victor, Cremniter Julie, Plouzeau Chloé, Michaud Anthony, Broutin Lauranne, Burucoa Christophe, Pichon Maxime

Abstract excerpt

BACKGROUND: Increasing antibiotic resistance in Helicobacter pylori necessitates research on new active molecules. In 2017, delafloxacin, a new fluoroquinolone with chemical properties of activity under acidic conditions, was approved for treatment of community-acquired bacterial pneumonia and acute bacterial skin and soft-tissue infections. Mutations in gyrA are responsible for fluoroquinolone resistance, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to DNA Gyrase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Fluoroquinolones

Share to Helicobacter Infections

Share to Helicobacter pylori

Share to Levofloxacin

Share to Microbial Sensitivity Tests

Source

Identifiers

PMID: 39126340
DOI: 10.1093/jac/dkae269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.PMID 39126340Read ↗

Antibiotic resistance of Helicobacter pylori in Nanjing, China: A cross-section study from 2018 to 2023Semantic proximity Read ↗

Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).Semantic proximity Read ↗

Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.Semantic proximity Read ↗

Novel DNA gyrase mutations in levofloxacin-resistant Helicobacter pylori isolates from southern VietnamSemantic proximity Read ↗

Updated Review on Clinically-Relevant Properties of DelafloxacinSemantic proximity Read ↗

[The application of genotypic resistance testing for clarithromycin and levofloxacin in different types of Helicobacter pylori infected patients based on gastric mucosal samples].Semantic proximity Read ↗

Antibiotic Resistance Landscape and Genomic Characterization of Helicobacter pylori in Western Inner Mongolia, ChinaSemantic proximity Read ↗

Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study.Semantic proximity Read ↗

Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacinSemantic proximity Read ↗

Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in NingxiaSemantic proximity Read ↗

High Antibiotic Resistance of Helicobacter pylori and Its Associated Novel Gene Mutations among the Mongolian PopulationSemantic proximity Read ↗

In vitro anti-Helicobacter pylori activity and phenotypic screening of novel quinolone compounds.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.